STOCK TITAN

Better Therapeutics to Participate in Two Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Better Therapeutics, Inc. (NASDAQ: BTTX), a leader in prescription digital therapeutics, is set to participate in two significant investor conferences in February and March 2023. The first event is the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on February 14-15, followed by the Cowen 43rd Annual Health Care Conference in Boston, MA on March 6, where the company will present at 11:10 a.m. ET. Better Therapeutics develops innovative cognitive behavioral therapy solutions aimed at addressing cardiometabolic diseases, focusing on long-term behavioral changes. A webcast of the Cowen presentation will be available for 30 days after the event on their website.

Positive
  • None.
Negative
  • None.

SAN FRANCISCO--(BUSINESS WIRE)-- Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced that the Company will participate in two upcoming investor conferences in February and March 2023.

  • BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held in Snowbird, UT on February 14 and 15, 2023.
  • Cowen 43rd Annual Health Care Conference being held in Boston, MA on March 6, 2023. Better Therapeutics is scheduled to present at 11:10 a.m. ET / 8:10 a.m. PT.

Better Therapeutics management will be available for one-on-one meetings during the conferences. The webcast and replay of the Cowen conference presentation will be available on the Presentations and Events page of the Better Therapeutics website at www.bettertx.com for approximately 30 days after the event.

About Better Therapeutics

Better Therapeutics is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The CBT delivered by Better Therapeutics’ PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics’ clinically validated mobile applications, if authorized for marketing, are intended to be prescribed by physicians and reimbursed like traditional medicines.

For more information visit: bettertx.com

Investor Relations:

Mark Heinen

IR@bettertx.com

Media:

Ryan McKenna at Real Chemistry

rmckenna@realchemistry.com

Source: Better Therapeutics, Inc.

FAQ

What will Better Therapeutics present at the Cowen 43rd Annual Health Care Conference?

Better Therapeutics will present at the Cowen 43rd Annual Health Care Conference on March 6, 2023, at 11:10 a.m. ET.

Where is Better Therapeutics participating in investor conferences in February 2023?

Better Therapeutics will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on February 14-15, 2023.

What is the focus of Better Therapeutics' digital therapeutics?

Better Therapeutics focuses on developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases.

How can investors access the Cowen conference presentation by Better Therapeutics?

Investors can access the webcast and replay of the Cowen conference presentation on the Presentations and Events page of Better Therapeutics' website for approximately 30 days.

What is the stock symbol for Better Therapeutics?

The stock symbol for Better Therapeutics is BTTX.

BETTER THERAPEUTICS INC

OTC:BTTX

BTTX Rankings

BTTX Latest News

BTTX Stock Data

5.45k
25.82M
48.23%
0.01%
3.9%
Biotechnology
Healthcare
Link
United States of America
San Francisco